About
Orthocell Ltd (AU:OCC) — investor relations, events, news, and company updates on 6ix.
Latest News
Yesterday
Compelling 90% Success Rate for Remplir in Real World Study
Apr 20 2026
Q3 FY26 Investor Presentation
Apr 17 2026
First Surgical Use of Remplir in US Department of Defense
Apr 15 2026
OCC Secures Access to 221 U.S. Military Medical Centres
Mar 18 2026
Remplir Used in 23 Surgeries in Ukrainian soldiers
Google Übersetzer